ANDREW RYMILL: Open Payments
NPI 1487107744 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,007 in 71 payments from 15 companies in 2025. Trend: 2023 $951 · 2024 $927 · 2025 $1,007
Food & beverage: $996Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $205 |
| ABBVIE INC. | 18 | $193 |
| Lilly USA, LLC | 11 | $167 |
| Phathom Pharmaceuticals, Inc. | 7 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $90 |
| Ardelyx, Inc. | 3 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| TerSera Therapeutics LLC | 1 | $36 |
| Novo Nordisk Inc | 2 | $34 |
| QOL Medical, LLC | 1 | $25 |
Products named: TREMFYA, OMVOH, VOQUEZNA, ENTYVIO, RINVOQ, SKYRIZI, IBSRELA, CREON.
Industry payments across LA — which companies pay providers there.
